Subfoveal Choroidal Thickness after Ranibizumab Therapy for Neovascular Age-related Macular Degeneration: 12-Month Results

Ophthalmology, 05/04/2012

Subfoveal choroidal thickness decreased after intravitreal injections of ranibizumab in eyes with neovascular age–related macular degeneration. Intravitreal injections of ranibizumab may provide a pharmacologic effect not only on the neovascular lesion but also on the underlying choroid.

Print Article Summary Cat 2 CME Report